Company: SYRA
Filing Date: 2025-02-05
Form Type: S-3/A
Source: 0001493152-25-005032
Chunk: 9

Company: Syra Health Corp
Filing Date: 2025-02-05
Form: S-3/A
Chunk 9
---
 to address the growing mental health crisis. We are strategically preparing for its launch in global markets while continually advancing its scientific foundation and AI technology to enhance user outcomes. Additionally, our government solutions service line of business positions us to work on federal government healthcare and related projects from several agencies such as the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the National Institutes of Health, the National Aeronautics and Space Administration and the United States Department of Defense.

| -3- |

Risks Associated with Our Business

Our business is subject to significant risks and uncertainties that make an investment in us speculative and risky. Below we summarize what we believe are the principal risk factors but these risks are not the only ones we face, and you should carefully review and consider the full discussion of our risk factors in the section titled “Risk Factors”, together with the other information in this prospectus and in the documents incorporated by reference herein . If any of the following risks actually occurs (or if any of those listed elsewhere or incorporated by reference into this prospectus occur), our business, reputation, financial condition, results of operations, revenue, and future prospects could be seriously harmed. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business.

Risks Related to Our Financial Position and Need for Additional Capital

| ● | Although                                                                                                                              
 we have generated approximately $6.0 million, $5.5 million and $5.6 million of revenues for the nine months ended September 30, 2024  
 and the years ended December 31, 2023 and 2022, respectively, our future profitability is uncertain.                                  |
| ● | We                                                                                                                                    
 will require substantial additional funding and if we are unable to raise capital on favorable terms when needed, we could be forced  
 to curtail, delay or discontinue our business.                                                                                        |
| ● | Our                                                                                                                                   
 independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern, which 
 may hinder our ability to obtain future financing.                                                                                    |

Risks Related to Our Business and Industry

| ● | Our                                                                                                                                     
 business strategy and future success depend on our ability to cross-sell our solutions.                                                 |
| ● | If                                                                                                                                      
 we are unable to successfully expand our sales force productivity, sales of our solutions and the growth of our business and financial  
 performance could be harmed.                                                                                                            |
| ● | Our                                                                                                                                     
 ability to